The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity.
Like many other autoimmune diseases, the antiphospholipid syndrome (APS) is considered as of a multifactorial etiology, mainly genetic susceptibility coinciding with environmental triggers, of which infectious agents are considered most prominent. Different clinical and experimental studies of the beta2 glycoprotein I (beta 2 GPI) molecule, one of the target autoantigens in APS, have linked infection to the development of APS. Using a peptide phage library, it has been shown that target epitopes of beta 2 GPI share similarities with common infectious pathogens. Also, circulating anti-beta 2 GPI antibodies have been identified in the sera of patients with different infectious conditions, and have been associated with various clinical APS manifestations. Molecular mimicry as a key mechanism linking infection and APS has been demonstrated in experimental models. In these studies, APS was induced by immunization of mice to various microbial pathogens. Anti-beta 2 GPI titers were found to be especially high following immunization with Haemophilus influenzae, Neisseria gonorrheae or tetanus toxoid. These findings contribute greatly to the understanding of APS pathogenesis, as well as create new directions for therapy modalities, namely specific peptide toleragens and antimicrobial treatment.
Harel
Michal
M
Department of Medicine 'B' and Center of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer 52621, Israel.
Aron-Maor
Anabel
A
Sherer
Yaniv
Y
Blank
Miri
M
Shoenfeld
Yehuda
Y
D000818:Animals; D016736:Antiphospholipid Syndrome / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology*; D015551:Autoimmunity; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D007239:Infections / Q000150:complications / Q000276:immunology; D018716:Molecular Mimicry; D014777:Virus Diseases / Q000150:complications / Q000276:immunology; D053482:beta 2-Glycoprotein I
D006023:Glycoproteins; D053482:beta 2-Glycoprotein I